Ms. Diana Lynne Sneek, LPN,AAPC,CEO Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 640 Fox Knoll Dr, #5, Lena, IL 61048 Phone: 815-232-2182 |
News Archive
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that the U.S. Patent & Trademark Office has granted and will reissue the composition of matter patent for picoplatin as RE41209, replacing USPN 5,665,771 ('771 patent), on April 6, 2010. The reissue was applied for May 8, 2009, and, on March 17, 2010, the USPTO released the "Issue Notification" for the reissue application.
In one of the first studies of its kind, a joint UCLA/RAND Corporation study addressed the prevalence and cost of critical care therapies provided in intensive care units that were perceived by physicians as "futile."
The race to develop an effective vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is on, with many vaccine candidates entering the human trial phase. When a vaccine is developed and introduced into the population at scale, it triggers herd immunity, with many people immune to the infectious disease.
The Buck Institute for Research on Aging and Biotica Technology Ltd. today announced a three-year collaboration to investigate polyketides in diseases of aging. Building on observations that rapamycin extends healthy lifespan in various species, the collaborators will evaluate rapamycin analogs and other polyketides in a broad range of age-related disease models to identify novel therapeutics.
› Verified 6 days ago